Recent advances highlight the critical role of metabolic dynamics within the tumor microenvironment influencing immune evasion in melanoma. Understanding how melanoma metabolism affects immunotherapy response opens new therapeutic avenues focused on metabolic reprogramming to overcome resistance. These insights could enhance efficacy of treatments in this challenging cancer type.